Cargando…
The clinical relevance of serum versus CSF NMDAR autoantibodies associated exclusively with psychiatric features: a systematic review and meta-analysis of individual patient data
BACKGROUND: A variety of psychiatric syndromes are associated with NMDAR autoantibodies; however, their clinical relevance when only present in the serum is unclear. We explored whether patients with CSF NMDAR autoantibodies could be distinguished from patients with serum-only NMDAR autoantibodies....
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467941/ https://www.ncbi.nlm.nih.gov/pubmed/35790561 http://dx.doi.org/10.1007/s00415-022-11224-6 |
_version_ | 1784788303404335104 |
---|---|
author | Blackman, Graham Lim, Mao Fong Pollak, Thomas Al-Diwani, Adam Symmonds, Mkael Mazumder, Asif Carter, Ben Irani, Sarosh David, Anthony |
author_facet | Blackman, Graham Lim, Mao Fong Pollak, Thomas Al-Diwani, Adam Symmonds, Mkael Mazumder, Asif Carter, Ben Irani, Sarosh David, Anthony |
author_sort | Blackman, Graham |
collection | PubMed |
description | BACKGROUND: A variety of psychiatric syndromes are associated with NMDAR autoantibodies; however, their clinical relevance when only present in the serum is unclear. We explored whether patients with CSF NMDAR autoantibodies could be distinguished from patients with serum-only NMDAR autoantibodies. METHODS: The electronic databases MEDLINE, EMBASE, PubMed, and PsycINFO were searched. Articles reporting adult patients with isolated psychiatric features and positive for NMDAR autoantibodies with relevant investigations were included. Patient level meta-analysis compared patients positive for CSF NMDAR autoantibodies with patients positive for serum NMDAR autoantibodies, but negative for CSF NMDAR autoantibodies. Dichotomous data were analysed using crude odds ratios (OR), whilst continuous data were analysed using Mann–Whitney Test (U). The protocol was prospectively registered (CRD42018082210). RESULTS: Of 4413 publications, 42 were included, reporting 79 patients. Median age was 34 years (IQR 19 years); 56% (45/79) were female and 24% (16/68) had a tumour. In total, 41 patients were positive for CSF autoantibodies and 20 were positive for serum-only autoantibodies. Patients with CSF autoantibodies were significantly more likely to be female (p < 0.001) and have a rapid (< 3 month) onset of symptoms (p = 0.02) than patients with serum-only autoantibodies. They were also more likely to present with psychosis (p < 0.001), exhibit EEG (p = 0.006), MRI (p = 0.002), and CSF (p = 0.001) abnormalities, but less likely to present with insomnia (p = 0.04). CONCLUSIONS: Patients with an isolated psychiatric syndrome with CSF NMDAR autoantibodies can potentially be distinguished from those with serum-only NMDAR autoantibodies based on clinicodemographic and investigation findings. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00415-022-11224-6. |
format | Online Article Text |
id | pubmed-9467941 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-94679412022-09-14 The clinical relevance of serum versus CSF NMDAR autoantibodies associated exclusively with psychiatric features: a systematic review and meta-analysis of individual patient data Blackman, Graham Lim, Mao Fong Pollak, Thomas Al-Diwani, Adam Symmonds, Mkael Mazumder, Asif Carter, Ben Irani, Sarosh David, Anthony J Neurol Review BACKGROUND: A variety of psychiatric syndromes are associated with NMDAR autoantibodies; however, their clinical relevance when only present in the serum is unclear. We explored whether patients with CSF NMDAR autoantibodies could be distinguished from patients with serum-only NMDAR autoantibodies. METHODS: The electronic databases MEDLINE, EMBASE, PubMed, and PsycINFO were searched. Articles reporting adult patients with isolated psychiatric features and positive for NMDAR autoantibodies with relevant investigations were included. Patient level meta-analysis compared patients positive for CSF NMDAR autoantibodies with patients positive for serum NMDAR autoantibodies, but negative for CSF NMDAR autoantibodies. Dichotomous data were analysed using crude odds ratios (OR), whilst continuous data were analysed using Mann–Whitney Test (U). The protocol was prospectively registered (CRD42018082210). RESULTS: Of 4413 publications, 42 were included, reporting 79 patients. Median age was 34 years (IQR 19 years); 56% (45/79) were female and 24% (16/68) had a tumour. In total, 41 patients were positive for CSF autoantibodies and 20 were positive for serum-only autoantibodies. Patients with CSF autoantibodies were significantly more likely to be female (p < 0.001) and have a rapid (< 3 month) onset of symptoms (p = 0.02) than patients with serum-only autoantibodies. They were also more likely to present with psychosis (p < 0.001), exhibit EEG (p = 0.006), MRI (p = 0.002), and CSF (p = 0.001) abnormalities, but less likely to present with insomnia (p = 0.04). CONCLUSIONS: Patients with an isolated psychiatric syndrome with CSF NMDAR autoantibodies can potentially be distinguished from those with serum-only NMDAR autoantibodies based on clinicodemographic and investigation findings. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00415-022-11224-6. Springer Berlin Heidelberg 2022-07-05 2022 /pmc/articles/PMC9467941/ /pubmed/35790561 http://dx.doi.org/10.1007/s00415-022-11224-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Blackman, Graham Lim, Mao Fong Pollak, Thomas Al-Diwani, Adam Symmonds, Mkael Mazumder, Asif Carter, Ben Irani, Sarosh David, Anthony The clinical relevance of serum versus CSF NMDAR autoantibodies associated exclusively with psychiatric features: a systematic review and meta-analysis of individual patient data |
title | The clinical relevance of serum versus CSF NMDAR autoantibodies associated exclusively with psychiatric features: a systematic review and meta-analysis of individual patient data |
title_full | The clinical relevance of serum versus CSF NMDAR autoantibodies associated exclusively with psychiatric features: a systematic review and meta-analysis of individual patient data |
title_fullStr | The clinical relevance of serum versus CSF NMDAR autoantibodies associated exclusively with psychiatric features: a systematic review and meta-analysis of individual patient data |
title_full_unstemmed | The clinical relevance of serum versus CSF NMDAR autoantibodies associated exclusively with psychiatric features: a systematic review and meta-analysis of individual patient data |
title_short | The clinical relevance of serum versus CSF NMDAR autoantibodies associated exclusively with psychiatric features: a systematic review and meta-analysis of individual patient data |
title_sort | clinical relevance of serum versus csf nmdar autoantibodies associated exclusively with psychiatric features: a systematic review and meta-analysis of individual patient data |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467941/ https://www.ncbi.nlm.nih.gov/pubmed/35790561 http://dx.doi.org/10.1007/s00415-022-11224-6 |
work_keys_str_mv | AT blackmangraham theclinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata AT limmaofong theclinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata AT pollakthomas theclinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata AT aldiwaniadam theclinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata AT symmondsmkael theclinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata AT mazumderasif theclinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata AT carterben theclinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata AT iranisarosh theclinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata AT davidanthony theclinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata AT blackmangraham clinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata AT limmaofong clinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata AT pollakthomas clinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata AT aldiwaniadam clinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata AT symmondsmkael clinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata AT mazumderasif clinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata AT carterben clinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata AT iranisarosh clinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata AT davidanthony clinicalrelevanceofserumversuscsfnmdarautoantibodiesassociatedexclusivelywithpsychiatricfeaturesasystematicreviewandmetaanalysisofindividualpatientdata |